Related Experiment Video
Updated: Dec 4, 2025
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.2K
Multidrug-Resistant Organisms in Palliative Care: A Systematic Review
Anna Enninger1, Pia Schmidt1,2, Carola Hasan2
1Department of Children's Pain Therapy and Pediatric Palliative Care, Faculty of Health, School of Medicine, Witten/Herdecke University, Witten, Germany.
Journal of Palliative Medicine
|October 21, 2020
Summary
Multidrug-resistant organisms (MDROs) pose a significant risk in palliative care (PC). Further research and public education are crucial to reduce MDRO transmission in this vulnerable population.
Area of Science:
- Healthcare Management
- Infectious Diseases
- Palliative Care
Background:
- Multidrug-resistant organisms (MDROs) are a growing concern in healthcare settings.
- Patients in palliative care (PC) are particularly vulnerable to MDRO colonization due to chronic conditions, compromised immunity, and device use.
Purpose of the Study:
- To systematically review the existing literature on multidrug-resistant organisms (MDROs) in palliative care (PC).
Main Methods:
- A systematic review was conducted using PubMed and CINAHL databases.
- The search was performed on October 19, 2019, and updated on May 16, 2020.
- Seventeen studies were included, comprising qualitative, quantitative, and mixed-methods research.
Main Results:
- Prevalence of MDRO colonization in PC settings ranged from 4.0% to 18%.
- MDRO colonization negatively impacts patients, families, and healthcare staff, increasing workload and uncertainty.
- Management strategies are primarily available for methicillin-resistant Staphylococcus aureus, with less than half of institutions utilizing existing protocols.
Conclusions:
- There is a significant need for more research on the prevalence of all MDROs in palliative care.
- Enhanced public awareness and education on MDROs are essential to reduce knowledge gaps and transmission.
- Improved resources, including staff, time, information, communication, and specific knowledge, are recommended for managing MDROs in PC.
More Related Videos
Related Concept Videos
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
01:28Pulmonary Tuberculosis V
351
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
351
01:27Combined Effects of Drugs: Synergism
6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.2K
01:28Pneumonia IV: Management
628
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
628
01:25Continuing Care
1.7K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.7K